Eric Rodriguez, MSPH

Eric Rodriguez is the Data Science Product Manager at Reboot Rx, where he leads the design and implementation of AI-driven systems that support the organization’s drug-repurposing platform. Since joining Reboot Rx in 2023, he has progressed through multiple roles, bridging data science, technology, and clinical research to accelerate low-cost cancer treatment innovation.

Eric played a key role in building the organization’s biomedical workbench and automated evidence-synthesis pipelines, significantly expanding the database of repurposing candidates across cancer types. His work improving model accuracy and information-extraction systems has strengthened Reboot Rx’s ability to translate complex biomedical data into actionable insights.

Prior to Reboot Rx, Eric worked at the Dana-Farber Cancer Institute, where he coordinated the CANVAS Trial and co-authored a manuscript cited in ASCO’s Venous Thromboembolism Guideline Update. He holds bachelor’s and master’s degrees in Public Health from Johns Hopkins University. Motivated by his personal experience as a cancer patient, Eric is committed to making effective, affordable cancer treatments accessible to all.